Epidemiology of Acute Respiratory Distress Syndrome in Chinese ICUs

June 13, 2020 updated by: Peking Union Medical College Hospital
The acute respiratory distress syndrome(ARDS)has a high morbidity and mortality in patients admitted to intensive care units(ICUs). It represents a significant public health issue. No large nationwide, multicenters study of ARDS has been conducted in China. The purposes of this study are to analyse: 1)the incidence and outcomes of ARDS in ICU; 2) factors associated the mortality ; and 3) risk factors for development of ARDS .

Study Overview

Status

Completed

Detailed Description

All patients admitted to the participating ICUs during a 6-month period(from January 1, 2015 to July 1,2015 ) will be screened at ICU admission and daily for the occurrence of ARDS ( AECC criteria) for a maximum of 28 days after ICU admission.

Data collection:

  1. For all patients, Demographic characteristics, admission category, the patient source intervention during ICU , APACHEII , SOFA score and discharge information will be collected
  2. For patients with ARDS, data about ABG , parameters of MV, hemodynamic on day0 to day7 and last day of MV will be collected.
  3. For patients without ARDS at ICU admission, data about risk factor for ARDS ,such as LIPS score, parameters of MV , and fluid balance on ICU day0 to day7 will be collected.

Study Type

Observational

Enrollment (Actual)

2530

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China
        • Peking University People's Hospital
      • Beijing, Beijing, China, 100730
        • MICU, Peking union medical college hospital
      • Beijing, Beijing, China
        • Beijing Hospital of Ministry of Health
      • Beijing, Beijing, China
        • Department of Critical Care Medicine, Fuxing Hospital, Capital Medical University
      • Beijing, Beijing, China
        • General ICU, Beijing Tongren Hospital, Capital Medical University
      • Beijng, Beijing, China
        • China-Japan Friendship Hospital
    • Chongqing
      • ChongQing, Chongqing, China
        • Department of Emergency and Intensive Care Medicine, The First Affiliated Hospital of Chongqing Medical University
    • Fujian
      • Fuzhou, Fujian, China
        • The First Affiliated Hospital of Fujian Medical University
    • Guangdong
      • Guangzhou, Guangdong, China
        • Department of CriticalCare Medicine, Guangdong General Hospital
    • Hainan
      • HaiKou, Hainan, China
        • Department of Critical Care Medicine, Hainan Provincial People's Hospital
    • Hebei
      • Shijiazhuang, Hebei, China
        • Department of Critical Care Medicine, Hebei Medical University Fourth Hospital
    • Heilongjiang
      • Harbin, Heilongjiang, China
        • Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University
    • Henan
      • Zhengzhou, Henan, China
        • ICU, The First Affiliated Hospital, Zhengzhou University
    • Hubei
      • WuHan, Hubei, China
        • Department of Critical Care Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science & Technology
    • Hunan
      • Changsha, Hunan, China
        • Department of Critical Care Medicine, Xiangya Hospital, Central South University
    • Inner Mongolia
      • Hohhot, Inner Mongolia, China
        • Department of Critical Care Medicine, The Affiliated Hopsital of Inner Mongolia Medical University
    • Jilin
      • ChangChun, Jilin, China
        • Department of Critical Care Medicine, The Second Hospital of Jilin University
    • Liaoning
      • Shenyang, Liaoning, China
        • Department of Critical Care Medicine, The First Affiliated Hospital of China Medical University
    • Ningxia
      • YinChuan, Ningxia, China
        • General Hospital of Ningxia Medical University
    • Shandong
      • Jinan, Shandong, China
        • Department of Critical Care Medicine, Qilu Hospital of Shandong University
    • Shanghai
      • Shanghai, Shanghai, China
        • Emergency ICU, Ruijin Hospital, Shanghai Jiao Tong University
    • Shanxi
      • XiAn, Shanxi, China
        • Surgical Intensive Care Unit, Xijing Hospital
    • Sichuan
      • Chengdu, Sichuan, China
        • Department of Critical Care Medicine, West China Hospital, Sichuan University
    • Xinjiang
      • Urumqi, Xinjiang, China
        • Department of Critical Care Medicine, First Affiliated Hospital, Xinjiang Medical University
    • Yunnan
      • Kunming, Yunnan, China
        • Department of Emergency Medicine and Medical ICU, The First Affiliated Hospital of Kunming Medical University
    • Zhejiang
      • Hangzhou, Zhejiang, China
        • Department of Critical Care Medicine, Zhejiang Provincial People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients admitted to the participating ICUs during a 6-month period(from January 1, 2015 to July 1,2015 )

Description

Inclusion Criteria:

all patients age >18 yrs admitted to 24 participating ICUs

Exclusion Criteria:

No patients should be excluded (regardless of age, underlying disease, life expectancy, etc).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
ARDS, non-ARDS
patients with ARDS and patients without ARDS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of acute respiratory distress syndrome (ARDS)
Time Frame: from ICU admission to 28-day of ICU stay
incidence of ARDS = the number of patients developing ARDS during ICU / the total number of patients admitted to ICU
from ICU admission to 28-day of ICU stay

Secondary Outcome Measures

Outcome Measure
Time Frame
ICU mortality of patients with ARDS
Time Frame: followed up to 3 months after inclusion or to ICU discharge, whichever occurred first
followed up to 3 months after inclusion or to ICU discharge, whichever occurred first
hospital mortality of patients with ARDS
Time Frame: followed up to 3 months after inclusion or to hospital discharge, whichever occurred first
followed up to 3 months after inclusion or to hospital discharge, whichever occurred first

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bin Du, MICU of Peking Union Medical College Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

May 18, 2015

First Submitted That Met QC Criteria

July 1, 2015

First Posted (Estimate)

July 3, 2015

Study Record Updates

Last Update Posted (Actual)

June 16, 2020

Last Update Submitted That Met QC Criteria

June 13, 2020

Last Verified

January 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome

Subscribe